DJ AbbVie Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ rallied 1.49% to $276.47 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.59% to 7,811.54 and the Dow Jones Industrial Average rising 0.83% to 51,654.95.
This was the stock's sixth consecutive day of gains.
AbbVie Inc. hit a new 52-week high, surpassing its previous peak of $274.94, which the company reached on October 7th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.93% to $261.44, Pfizer Inc. $(PFE)$ rose 1.65% to $28.28, and Amgen Inc. $(AMGN)$ rose 1.82% to $414.87.
Trading volume (4.3 M) remained 413,973 below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.